期刊文献+

肝移植术后脓毒症:1例报告并国际严重脓毒症和脓毒症休克指南解读

Sepsis after liver transplantation: a report of one case and interpretation of International Guidelines for Management of Severe Sepsis and Septic Shock
下载PDF
导出
摘要 目的总结肝移植术后脓毒症的治疗经验。方法回顾性分析2014年9月中山大学附属第三医院外科重症监护室收治的1例肝移植术后脓毒症的临床特征及治疗方法,并复习国际严重脓毒症和脓毒症休克治疗指南(SSC指南)解读及相关文献。结果 1例50岁男性患者在肝移植术后1 d出现高热、血压下降,诊断为感染性休克,经过适当的目标导向性液体复苏、抗感染、血液净化等治疗获得缓解,患者病情稳定出院。结论肝移植术后患者易发生感染,由感染引起的脓毒症病死率高,因此一旦发生脓毒症,临床医师要积极地按照SSC指南进行早期的目标导向性治疗及集束化治疗,根据病原培养结果选用合适的药物,降低病死率。 Objective To summarize the treatment experience of sepsis after liver transplantation.Methods The clinical features and treatment methods of 1 patient developing sepsis after liver transplantation, who was admitted and treated in the Surgical Intensive Care Unit of the Third Affiliated Hospital of Sun Yat-sen University in September 201 4,were retrospectively studied.The interpretation of International Guidelines for Management of Severe Sepsis and Septic Shock (SSC Guidelines)and relevant literature were reviewed.Results One male patient at the age of 50 years old developed high fever and decrease of blood pressure at 1 d after liver transplantation,and was diagnosed as septic shock.The symptoms were relieved after the appropriate treatment like goal-directed fluid resuscitation,anti-infection and blood purification,etc.And the patient was discharged in stable conditions.Conclusions It is easy to develop infection after liver transplantation and the fatality rate of sepsis caused by infection is high.Once the sepsis occurs,clinicians must perform early goal-directed therapy and bundle therapy according to the SSC Guidelines positively,and select the appropriate drugs according to the pathogen culture results in order to reduce the fatality rate.
出处 《器官移植》 CAS CSCD 2015年第6期378-381,共4页 Organ Transplantation
基金 广州市科技计划项目(2011Y1-0033-1)
关键词 肝移植 感染 脓毒症 抗感染 血液净化 Liver transplantation Infection Sepsis Anti-infection Blood purification
  • 相关文献

参考文献22

  • 1Drewry AM, Hotchkiss RS. Sepsis: revising definitions of sepsis[J]. Nat Rev Nephrol, 2015, 11 (6): 326- 328.
  • 2Brown T, Ghelani-Allen A, Yeung D, et al, Comparative effectiveness of physician diagnosis and guideline definitions in identifying sepsis patients in the emergency department[J].J Crit Care, 2015, 30 (1): 71-77.
  • 3Balk RA. Systemic inflammatory response syndrome ( SIRS) : where did it come from and is it still relevant today?[J]. Virulence, 2014, 5 (1): 20-26.
  • 4Gu WJ, Wang F, BakkerJ, et a1. The effect of goal?directed therapy on mortality in patients with sepsis?earlier is better: a meta-analysis of randomized controlled trials[J]. Crit Care, 2014, 18 (5): 570.
  • 5Wan YD, Sun TW, Kan QC, et al. Effect of statin therapy on mortality from infection and sepsis: a meta?analysis of randomized and observational studies[J]. Crit Care, 2014, 18 (2): R7l.
  • 6Page DB, DonnellyJP, Wang HE. Community-, healthcare-, and hospital-acquired severe sepsis hospitalizations in the University Health System Consortium[J]. Crit Care Med, 2015, 43 (9): 1945- 1951.
  • 7Goodwin AJ, Simpson KN, Ford DW. Volume-mortality relationships during hospitalization with severe sepsis exist only at low case volumes[J]. Ann Am Thorac Soc, 2015, 12 (8): 1177-1184.
  • 8胡海清,周庭银,唐德羽,陈险峰,邵敏伟.肝移植术后革兰阴性杆菌感染的种类及耐药性分析[J].实用医学杂志,2008,24(16):2880-2882. 被引量:6
  • 9FishbainJ, Peleg A Y. Treatment of acinetobacter infections[J]. Clin Infect Dis, 2010, 51 (1): 79-84.
  • 10Munoz-Price LS, Weinstein RA. Acinetobacter infection[J]. N EnglJ Med, 2008, 358 (12): 1271-1281.

二级参考文献24

共引文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部